Form 8-K ARIAD PHARMACEUTICALS For: Dec 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
ARIAD Pharma (ARIA) Receives Payments from Bellicum (BLCM)
December 30, 2014 4:20 PM ESTAs previously disclosed, in October 2014, ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) entered into an agreement with Bellicum Pharmaceuticals, Inc. (Bellicum) (Nasdaq: BLCM) to restructure and amend an existing license agreement between the companies for ARIADs cell-signaling technology. Under the... More
